CN103565959A - Decoction for treating schizophrenia - Google Patents

Decoction for treating schizophrenia Download PDF

Info

Publication number
CN103565959A
CN103565959A CN201310540745.2A CN201310540745A CN103565959A CN 103565959 A CN103565959 A CN 103565959A CN 201310540745 A CN201310540745 A CN 201310540745A CN 103565959 A CN103565959 A CN 103565959A
Authority
CN
China
Prior art keywords
parts
decoction
treatment
herba
schizoid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201310540745.2A
Other languages
Chinese (zh)
Other versions
CN103565959B (en
Inventor
阮玖琼
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Li Chuanping
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201310540745.2A priority Critical patent/CN103565959B/en
Publication of CN103565959A publication Critical patent/CN103565959A/en
Application granted granted Critical
Publication of CN103565959B publication Critical patent/CN103565959B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to decoction for treating schizophrenia. The decoction is prepared from the following bulk drugs and pharmaceutically acceptable carriers in parts by weight: bilobate grewia, rhamnus napelensis, rooted pellionia herb, leontopodium wilsonii beauvd, impatiens noli-tangere, fiddlehead fern, parmelia tinctorum despr and wintercreeper. Clinical application discovers that the decoction for treating schizophrenia has the advantages of quick response, remarkable treatment effect, good tolerance, low cost and no toxic or side effect.

Description

A kind ofly treat schizoid decoction
Technical field
The present invention relates to psychosis prevention field, specifically, relate to a kind of schizoid decoction for the treatment of.
Background technology
Schizophrenia is mainly in person between twenty and fifty, and patient's learning life and family social have all been caused to serious impact, therefore schizoid treatment is very urgent.Continue to bring out in recent years the antipsychotic drug making new advances, but mostly be chemicals, side effect is larger.For making clinical treatment have more selection, develop new medicine necessary.
Summary of the invention
The object of this invention is to provide a kind of schizoid decoction for the treatment of.
In order to realize object of the present invention, the invention provides a kind of schizoid decoction for the treatment of, it is to be made by weight by following bulk drugs and pharmaceutically acceptable carrier: Radix grewiae bilobae 3-10 part, longestapex beautyberry leaf 10-20 part, Herba Pellioniae minimae 10-30 part, little loose 5-10 part, Flos seu Radix Impatientis nolitangeris 10-20 part, Herba Fimbristylis dichotomae 1-10 part, Parmelia tinctorum Despr. 1-15 part and Caulis Seu Folium Euonymi Fortunei 5-10 part.
Preferably, the schizoid decoction for the treatment of of the present invention is to be made by weight by following bulk drugs and pharmaceutically acceptable carrier: 8 parts of 7 parts of Radix grewiae bilobae, 14 parts of longestapex beautyberry leafs, 22 parts of Herba Pellioniae minimaes, 8 parts of little ground pines, 16 parts of water gold wind, 8 parts of Herba Fimbristylis dichotomae, 11 parts of Parmelia tinctorum Despr. and Caulis Seu Folium Euonymi Fortuneis.
With reference to < < Chinese medicine voluminous dictionary > > second edition, being described as follows of the crude drug using in the present invention:
Figure BSA0000097132250000011
Figure BSA0000097132250000021
In the schizoid decoction for the treatment of of the present invention, use natural drug, through clinical practice, find, have effect rapidly, therapeutic effect obviously, better tolerance, advantage with low cost, without any side effects.
The specific embodiment
Below the invention will be further described for the description by the specific embodiment, but this is not limitation of the present invention, those skilled in the art are according to basic thought of the present invention, can make various modifications or improvement, but only otherwise depart from basic thought of the present invention, all within the scope of the present invention.
The preparation of embodiment 1 decoction of the present invention
Get 8 grams of 7 grams of Radix grewiae bilobae, 14 grams of longestapex beautyberry leafs, 22 grams of Herba Pellioniae minimaes, 8 grams of little ground pines, 16 grams of Flos seu Radix Impatientis nolitangeriss, 8 grams of Herba Fimbristylis dichotomae, 11 grams of Parmelia tinctorum Despr. and Caulis Seu Folium Euonymi Fortuneis, add 7000 ml waters, under the condition of 1 normal atmosphere, backflow, heat 3 hours.Be cooled to room temperature, filter, filtrate is decoction of the present invention.
Test example
1. patient's situation: 40 routine patients, male 20 examples, female's 20 examples, the oldest person is 68 years old, reckling is 25 years old, average 45 years old.The elder of medical history is 5 years, and the shortest person is 4 months, average 2 years 6 months.Be divided into treatment group and matched group, every group of 20 examples, wherein 2 groups of patient's parameters there was no significant differences.
2. diagnostic criteria: all cases all meet < < Chinese Spirit Disease Diagnosis Standard CCMD-3 > > (Zhang Mingyuan. psychiatric department rating scale handbook [M]. Changsha: Hunan science tech publishing house, 1993.p81-95), got rid of and suffered from serious physical disease, epilepsy, organic disease person.Show as clinically life sluggishness, paraphrenia, speak to oneself solely laugh at, cold, unsociable and eccentric to people, lack to move, the symptom such as complexion is pale, be afraid of cold.
3. Therapeutic Method: above-mentioned treatment group and matched group are observed to 3 months time.The decoction of oral embodiment 1 preparation for the treatment of group, every day 1 time, each 100 milliliters.The oral LVANPING of matched group (purchased from Yangzhou Zhongbao Pharmaceutical Co., Ltd.), every day 2 times, 200 milligrams of each dosage.In therapeutic process, forbid other drug.
4. criterion of therapeutical effect: recovery from illness: psychotic symptoms disappears completely, and thinking compared with normal, is emotionally stable, it is normal that social function is recovered.Effective: psychotic symptoms is most of to disappear, and thinking compared with normal, is emotionally stable, and social function is obviously recovered, and insight has part to recover.Effective: psychotic symptoms partly disappears, thinking is more random, flat affect, and insight partly recovers.Invalid: symptom is without improvement, without insight.
5. therapeutic outcome
The result for the treatment of after 3 months is as shown in table 1 below.
The comparison of table 1 liang group clinical treatment result
Figure BSA0000097132250000041
As seen from the above table, the successful for the treatment of group is better than the therapeutic effect of matched group.
Untoward reaction and toxic and side effects supervision
During treating, by detect patient blood pressure, pulse, whether occur feeling sick, vomiting, dizzy clinical symptoms judge the untoward reaction for the treatment of group.Find that 20 routine patients' the systolic pressure for the treatment of group is between 90-140mmHg, diastolic pressure is between 60-90mmHg, and pulse is 60-100 beat/min, and blood pressure and pulse all within normal range, and not have to occur nauseating, vomiting, dizzy clinical symptoms.This illustrates that pharmaceutical composition of the present invention does not have obvious untoward reaction, and then proves that this medicine does not have obvious toxic and side effects for human body.

Claims (2)

1. the schizoid decoction for the treatment of, is characterized in that, it canby following bulk drugs and pharmaceutically acceptable carrier, made by weight: Radix grewiae bilobae 3-10 part, longestapex beautyberry leaf 10-20 part, Herba Pellioniae minimae 10-30 part, little loose 5-10 part, Flos seu Radix Impatientis nolitangeris 10-20 part, Herba Fimbristylis dichotomae 1-10 part, Parmelia tinctorum Despr. 1-15 part and Caulis Seu Folium Euonymi Fortunei 5-10 part.
2. the schizoid decoction for the treatment of according to claim 1, is characterized in that, it canby following bulk drugs and pharmaceutically acceptable carrier, made by weight: 8 parts of 7 parts of Radix grewiae bilobae, 14 parts of longestapex beautyberry leafs, 22 parts of Herba Pellioniae minimaes, 8 parts of little ground pines, 16 parts of Flos seu Radix Impatientis nolitangeriss, 8 parts of Herba Fimbristylis dichotomae, 11 parts of Parmelia tinctorum Despr. and Caulis Seu Folium Euonymi Fortuneis.
CN201310540745.2A 2013-11-06 2013-11-06 Decoction for treating schizophrenia Expired - Fee Related CN103565959B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310540745.2A CN103565959B (en) 2013-11-06 2013-11-06 Decoction for treating schizophrenia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310540745.2A CN103565959B (en) 2013-11-06 2013-11-06 Decoction for treating schizophrenia

Publications (2)

Publication Number Publication Date
CN103565959A true CN103565959A (en) 2014-02-12
CN103565959B CN103565959B (en) 2015-04-08

Family

ID=50039240

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310540745.2A Expired - Fee Related CN103565959B (en) 2013-11-06 2013-11-06 Decoction for treating schizophrenia

Country Status (1)

Country Link
CN (1) CN103565959B (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1235541A (en) * 1996-08-30 1999-11-17 Nps药物有限公司 Treatment of spasticity, convulsions by isovaleric acid derivatives CNS
CN1366948A (en) * 2001-01-20 2002-09-04 杨孟君 Nano Fufang Fufangteng preparation medicine and preparation method
US20110159129A1 (en) * 2009-12-31 2011-06-30 National Taiwan University Use of clerodendrum sp. for treating tic disorders or psychiatric disorders with sensorimotor gating deficits
CN102357115A (en) * 2011-10-12 2012-02-22 广西中医学院制药厂 Sugar-free compound wintercreeper mixture and production method thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1235541A (en) * 1996-08-30 1999-11-17 Nps药物有限公司 Treatment of spasticity, convulsions by isovaleric acid derivatives CNS
CN1366948A (en) * 2001-01-20 2002-09-04 杨孟君 Nano Fufang Fufangteng preparation medicine and preparation method
US20110159129A1 (en) * 2009-12-31 2011-06-30 National Taiwan University Use of clerodendrum sp. for treating tic disorders or psychiatric disorders with sensorimotor gating deficits
CN102357115A (en) * 2011-10-12 2012-02-22 广西中医学院制药厂 Sugar-free compound wintercreeper mixture and production method thereof

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
南京中医药大学: "《中药大辞典》", 31 March 2006, 上海科学技术出版社 *
宋通贵: "浅谈精神分裂症的分型及中医辨证施治", 《中国民族民间医药》 *
赖群清: "120例慢性精神分裂症中医辨证分型临床调查分析", 《中医药学刊》 *
黑龙江省中医学会: "《参加中华中医学会学术会议学术资料》", 30 April 1979 *

Also Published As

Publication number Publication date
CN103565959B (en) 2015-04-08

Similar Documents

Publication Publication Date Title
CN101530579B (en) A pharmaceutical composition for soothing the nerves
CN101579511B (en) Drug combination used for treating schizophrenia
CN105769789A (en) Clozapine tablets for treating schizophrenia and preparation method thereof
CN105395600A (en) Application of cyclocarya paliurus extract in preparing medicine for treating cardiovascular and cerebrovascular diseases
CN103565959B (en) Decoction for treating schizophrenia
CN102961726B (en) Agentia for treating schizophrenia
CN103550477B (en) Medicament for treating herpes zoster
CN103721068B (en) A kind of medicament for the treatment of infantile anorexia
CN103041350A (en) Decoction for treating schizophrenia
CN104800437B (en) One treats schizoid medicine
CN103211802A (en) Novel application of phloroglucinol
CN103566225B (en) Medicament for treating gynecological postoperative gastrointestinal dysfunction
CN103721069B (en) A kind of preparation method for the treatment of the medicament of infantile anorexia
CN103520458B (en) Pharmaceutical composition for calming the nerves on a kind of psychiatric nursing
CN1119995C (en) Camphor liniment
CN104784332B (en) A kind of preparation method of the medicament treating Chronic Urinary Tract Infection
CN104771560B (en) A kind of medicine for the treatment of mania
CN104055943A (en) Medicament for treating ulcerative colitis
CN102657777B (en) Medicament for treatment of neurasthenia
CN102671048B (en) Medicament for treating chronic urinary tract infections
CN103550459B (en) A kind of preparation method for the treatment of the medicament of infantile asthma
CN104056028A (en) Medicament for treating ulcerative colitis
CN103550519A (en) Preparation method of medicament for treating dysmenorrhea
CN104825869B (en) A kind of medicine for the treatment of anxiety neurosis
CN103566077B (en) A kind of medicament for the treatment of hysteromyoma

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
ASS Succession or assignment of patent right

Owner name: LI CHUANPING

Free format text: FORMER OWNER: RUAN JIUQIONG

Effective date: 20150304

C41 Transfer of patent application or patent right or utility model
C53 Correction of patent of invention or patent application
CB03 Change of inventor or designer information

Inventor after: Li Chuanping

Inventor before: Ruan Jiuqiong

COR Change of bibliographic data

Free format text: CORRECT: INVENTOR; FROM: RUAN JIUQIONG TO: LI CHUANPING

TA01 Transfer of patent application right

Effective date of registration: 20150304

Address after: 272051 Shandong province in Rencheng District of Jining City North wear Zhuangji wear Road No. 1 Jining city mental hospital

Applicant after: Li Chuanping

Address before: 272051 Shandong Province in Rencheng District of Jining City North wearing Zhuangji wearing No. 1 Shandong Road, Jining city mental hospital

Applicant before: Ruan Jiuqiong

C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20150408

Termination date: 20151106

EXPY Termination of patent right or utility model